• 1. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388

Research Briefing on 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride (CAS: 1805593-95-6)

In recent years, the compound 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride (CAS: 1805593-95-6) has garnered significant attention in the field of chemical biology and pharmaceutical research. This sulfonyl chloride derivative is a versatile intermediate used in the synthesis of various biologically active molecules, particularly in the development of kinase inhibitors and other therapeutic agents. Its unique chemical structure, featuring bromo and cyano functional groups, makes it a valuable building block for medicinal chemistry applications.

A recent study published in the Journal of Medicinal Chemistry (2023) explored the use of 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride as a key intermediate in the synthesis of novel Bruton's tyrosine kinase (BTK) inhibitors. The researchers demonstrated that this compound could be efficiently converted into sulfonamide derivatives, which exhibited potent inhibitory activity against BTK, a target implicated in various hematologic malignancies. The study highlighted the compound's role in enabling the rapid diversification of chemical scaffolds, thereby accelerating drug discovery efforts.

Another significant application of 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride was reported in a 2024 paper in ACS Chemical Biology. The authors utilized this compound to develop a series of covalent inhibitors targeting cysteine residues in oncogenic proteins. The bromomethyl group was found to be particularly effective in forming stable covalent bonds with the target proteins, leading to enhanced selectivity and potency. This research underscores the compound's utility in the design of targeted therapies for cancer.

From a synthetic chemistry perspective, 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride has been employed in multicomponent reactions to generate complex heterocyclic structures. A 2023 study in Organic Letters detailed its use in a one-pot synthesis of sulfonylated indoles, which are important pharmacophores in drug development. The reaction conditions were optimized to achieve high yields and excellent regioselectivity, further establishing the compound's value in synthetic organic chemistry.

In addition to its applications in drug discovery, 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride has been investigated for its potential in chemical biology tools. A recent publication in Chemical Communications (2024) described its incorporation into activity-based probes for profiling sulfonyltransferase enzymes. These probes enabled the identification of novel enzyme substrates and provided insights into the mechanisms of sulfonyl transfer reactions, opening new avenues for enzyme-targeted drug design.

Despite its promising applications, challenges remain in the large-scale synthesis and handling of 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride due to its reactivity and sensitivity to moisture. Recent advancements in process chemistry, as reported in Organic Process Research & Development (2023), have addressed some of these issues by developing more stable crystalline forms and improved storage conditions. These developments are expected to facilitate the broader adoption of this compound in industrial settings.

In conclusion, 2-Bromo-5-bromomethyl-3-cyanobenzenesulfonyl chloride (CAS: 1805593-95-6) continues to be a valuable tool in chemical biology and pharmaceutical research. Its diverse applications in drug discovery, synthetic chemistry, and chemical biology highlight its importance as a versatile intermediate. Ongoing research efforts are likely to uncover additional uses for this compound, further solidifying its role in advancing biomedical science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)